Comment by jkp56

If you are a VC and want to fund a biotech startup, something in this promising crispr field, it makes more sense to invest into 100 ex-bigpharma-scientists, than into some smooth talkers that wear nice suits. The ideal situation is when founders are ex execs from big industry who actually know how stuff works, but VCs don't have this luxury of choice.